Abstract
Curcumin (CUR) is a yellow-coloured polyphenolic compound obtained from the rhizomes of Curcuma longa. In-depth pharmacological screening of curcumin has given the evidence that CUR persuades shielding and curative effects against various cancers, cardiovascular, wound healing effect and neuro disorders etc owning to anti-oxidant, antiproliferative, anti-inflammatory, anti-angiogenic and antimicrobial activities. However, miserable bioavailability due to poor aqueous solubility limits the application of CUR in various ailments. Different methodologies including the nanoparticle technology have been reported for the bioavailability enhancement of CUR. Nanoparticles exhibit not only the improvement in the solubility of CUR and alike lipophilic molecules (resulted in improved bioavailability) but also giving the opportunity for the disease specific cellular and organ targeting. Improved bioavailability and disease based site specific delivery of CUR is more likely to bring it as a safe multifunctional medicine.
Keywords: Anticancer, anti-inflammatory, bioavailability, curcumin nanocarriers, curcumin, nanocurcumin, nanoparticles, neuroprotective, solid lipid nanoparticles.
Current Drug Discovery Technologies
Title:Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap
Volume: 11 Issue: 3
Author(s): Mohammad Zaki Ahmad, Shabib Akhter, Nehal Mohsin, Basel A. Abdel-Wahab, Javed Ahmad, Musarrat Husain Warsi, Mahfoozur Rahman, Neha Mallick and Farhan Jalees Ahmad
Affiliation:
Keywords: Anticancer, anti-inflammatory, bioavailability, curcumin nanocarriers, curcumin, nanocurcumin, nanoparticles, neuroprotective, solid lipid nanoparticles.
Abstract: Curcumin (CUR) is a yellow-coloured polyphenolic compound obtained from the rhizomes of Curcuma longa. In-depth pharmacological screening of curcumin has given the evidence that CUR persuades shielding and curative effects against various cancers, cardiovascular, wound healing effect and neuro disorders etc owning to anti-oxidant, antiproliferative, anti-inflammatory, anti-angiogenic and antimicrobial activities. However, miserable bioavailability due to poor aqueous solubility limits the application of CUR in various ailments. Different methodologies including the nanoparticle technology have been reported for the bioavailability enhancement of CUR. Nanoparticles exhibit not only the improvement in the solubility of CUR and alike lipophilic molecules (resulted in improved bioavailability) but also giving the opportunity for the disease specific cellular and organ targeting. Improved bioavailability and disease based site specific delivery of CUR is more likely to bring it as a safe multifunctional medicine.
Export Options
About this article
Cite this article as:
Ahmad Zaki Mohammad, Akhter Shabib, Mohsin Nehal, Abdel-Wahab A. Basel, Ahmad Javed, Warsi Husain Musarrat, Rahman Mahfoozur, Mallick Neha and Ahmad Jalees Farhan, Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap, Current Drug Discovery Technologies 2014; 11 (3) . https://dx.doi.org/10.2174/1570163811666140616153436
DOI https://dx.doi.org/10.2174/1570163811666140616153436 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Traditional Risk Factors for Coronary Atherosclerosis in Indo Asians: The Need for a Reappraisal
Current Pharmaceutical Design Neuroprotection by vitamin C against ethanol -induced neuroinflammation associated neurodegeneration in developing rat brain
CNS & Neurological Disorders - Drug Targets Ion Channel Defects in Idiopathic Epilepsies
Current Pharmaceutical Design The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option
Current Neuropharmacology Polysialyltransferase: A New Target in Metastatic Cancer
Current Cancer Drug Targets Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Management of Prehypertension: Current Status and Future Strategies
Current Hypertension Reviews Fluorescein-Inspired Near-Infrared Chemodosimeter for Luminescence Bioimaging
Current Medicinal Chemistry Pharmacogenetic Testing for Clopidogrel: State of the ART
Current Pharmacogenomics and Personalized Medicine Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers
Current Psychiatry Reviews Cancer Drug Development Using Glucose Metabolism Radiopharmaceuticals
Current Pharmaceutical Design Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
Current Diabetes Reviews Cell Immunity in Coronary Artery Disease (CAD)
Current Immunology Reviews (Discontinued) Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
Current Alzheimer Research Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design The Role of Oxidative Stress, Adhesion Molecules and Antioxidants in Preeclampsia
Current Hypertension Reviews Renin--Angiotensin System Gene Polymorphism and Regression of Left Ventricular Hypertrophy in Hypertension
Current Pharmacogenomics Insulin Secretion and Interleukin-1β Dependent Mechanisms in Human Diabetes Remission After Metabolic Surgery
Current Medicinal Chemistry Physical Means of Stratum Corneum Barrier Manipulation to Enhance Transdermal Drug Delivery
Current Drug Delivery Multi-scale LBP and SVM Classification to Identify Diabetic Retinopathy in Lesions
Current Medical Imaging